Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Kaposi's Sarcoma-Associated Herpesvirus-Encoded Viral IL-6 (vIL-6) Enhances Immunoglobulin Class-Switch Recombination.

Rosario SA, Santiago GE, Mesri EA, Verdun RE.

Front Microbiol. 2018 Dec 18;9:3119. doi: 10.3389/fmicb.2018.03119. eCollection 2018.

2.

KSHV-induced ligand mediated activation of PDGF receptor-alpha drives Kaposi's sarcomagenesis.

Cavallin LE, Ma Q, Naipauer J, Gupta S, Kurian M, Locatelli P, Romanelli P, Nadji M, Goldschmidt-Clermont PJ, Mesri EA.

PLoS Pathog. 2018 Jul 9;14(7):e1007175. doi: 10.1371/journal.ppat.1007175. eCollection 2018 Jul.

3.

Kaposi sarcoma-associated herpesvirus promotes tumorigenesis by modulating the Hippo pathway.

Liu G, Yu FX, Kim YC, Meng Z, Naipauer J, Looney DJ, Liu X, Gutkind JS, Mesri EA, Guan KL.

Oncogene. 2015 Jul;34(27):3536-46. doi: 10.1038/onc.2014.281. Epub 2014 Sep 8.

4.

Molecular and cellular mechanisms of KSHV oncogenesis of Kaposi's sarcoma associated with HIV/AIDS.

Cavallin LE, Goldschmidt-Clermont P, Mesri EA.

PLoS Pathog. 2014 Jul 10;10(7):e1004154. doi: 10.1371/journal.ppat.1004154. eCollection 2014 Jul. Review. No abstract available.

5.

Human viral oncogenesis: a cancer hallmarks analysis.

Mesri EA, Feitelson MA, Munger K.

Cell Host Microbe. 2014 Mar 12;15(3):266-82. doi: 10.1016/j.chom.2014.02.011. Review.

6.

Glycosylation-dependent lectin-receptor interactions preserve angiogenesis in anti-VEGF refractory tumors.

Croci DO, Cerliani JP, Dalotto-Moreno T, Méndez-Huergo SP, Mascanfroni ID, Dergan-Dylon S, Toscano MA, Caramelo JJ, García-Vallejo JJ, Ouyang J, Mesri EA, Junttila MR, Bais C, Shipp MA, Salatino M, Rabinovich GA.

Cell. 2014 Feb 13;156(4):744-58. doi: 10.1016/j.cell.2014.01.043.

7.

Productively infected murine Kaposi's sarcoma-like tumors define new animal models for studying and targeting KSHV oncogenesis and replication.

Ashlock BM, Ma Q, Issac B, Mesri EA.

PLoS One. 2014 Jan 28;9(1):e87324. doi: 10.1371/journal.pone.0087324. eCollection 2014.

8.

Molecular studies and therapeutic targeting of Kaposi's sarcoma herpesvirus (KSHV/HHV-8) oncogenesis.

Mesri EA, Cavallin LE, Ashlock BM, Leung HJ, Ma Q, Goldschmidt-Clermont PJ.

Immunol Res. 2013 Dec;57(1-3):159-65. doi: 10.1007/s12026-013-8458-z. Review.

PMID:
24203444
9.

CD30 targeting with brentuximab vedotin: a novel therapeutic approach to primary effusion lymphoma.

Bhatt S, Ashlock BM, Natkunam Y, Sujoy V, Chapman JR, Ramos JC, Mesri EA, Lossos IS.

Blood. 2013 Aug 15;122(7):1233-42. doi: 10.1182/blood-2013-01-481713. Epub 2013 Jul 9.

10.

Efficacious proteasome/HDAC inhibitor combination therapy for primary effusion lymphoma.

Bhatt S, Ashlock BM, Toomey NL, Diaz LA, Mesri EA, Lossos IS, Ramos JC.

J Clin Invest. 2013 Jun;123(6):2616-28. doi: 10.1172/JCI64503. Epub 2013 May 1.

11.

Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma.

Croci DO, Salatino M, Rubinstein N, Cerliani JP, Cavallin LE, Leung HJ, Ouyang J, Ilarregui JM, Toscano MA, Domaica CI, Croci MC, Shipp MA, Mesri EA, Albini A, Rabinovich GA.

J Exp Med. 2012 Oct 22;209(11):1985-2000. doi: 10.1084/jem.20111665. Epub 2012 Oct 1.

12.

Activation of the unfolded protein response by 2-deoxy-D-glucose inhibits Kaposi's sarcoma-associated herpesvirus replication and gene expression.

Leung HJ, Duran EM, Kurtoglu M, Andreansky S, Lampidis TJ, Mesri EA.

Antimicrob Agents Chemother. 2012 Nov;56(11):5794-803. doi: 10.1128/AAC.01126-12. Epub 2012 Aug 27.

13.

A role for virally induced reactive oxygen species in Kaposi's sarcoma herpesvirus tumorigenesis.

Ma Q, Cavallin LE, Leung HJ, Chiozzini C, Goldschmidt-Clermont PJ, Mesri EA.

Antioxid Redox Signal. 2013 Jan 1;18(1):80-90. doi: 10.1089/ars.2012.4584. Epub 2012 Aug 20.

14.

Kaposi's sarcoma herpesvirus oncogenesis is a notch better in 3D.

Mesri EA, Cesarman E.

Cell Host Microbe. 2011 Dec 15;10(6):529-31. doi: 10.1016/j.chom.2011.11.008.

15.

Novel alkynylphosphonate analogue of calcitriol with potent antiproliferative effects in cancer cells and lack of calcemic activity.

Salomón DG, Grioli SM, Buschiazzo M, Mascaró E, Vitale C, Radivoy G, Perez M, Fall Y, Mesri EA, Curino AC, Facchinetti MM.

ACS Med Chem Lett. 2011 Apr 11;2(7):503-8. doi: 10.1021/ml200034w. eCollection 2011 Jul 14.

16.

Kaposi's sarcoma and its associated herpesvirus.

Mesri EA, Cesarman E, Boshoff C.

Nat Rev Cancer. 2010 Oct;10(10):707-19. doi: 10.1038/nrc2888. Review.

17.

Efficacy of bortezomib in a direct xenograft model of primary effusion lymphoma.

Sarosiek KA, Cavallin LE, Bhatt S, Toomey NL, Natkunam Y, Blasini W, Gentles AJ, Ramos JC, Mesri EA, Lossos IS.

Proc Natl Acad Sci U S A. 2010 Jul 20;107(29):13069-74. doi: 10.1073/pnas.1002985107. Epub 2010 Jul 6.

18.

Massive secretion by T cells is caused by HIV Nef in infected cells and by Nef transfer to bystander cells.

Muratori C, Cavallin LE, Krätzel K, Tinari A, De Milito A, Fais S, D'Aloja P, Federico M, Vullo V, Fomina A, Mesri EA, Superti F, Baur AS.

Cell Host Microbe. 2009 Sep 17;6(3):218-30. doi: 10.1016/j.chom.2009.06.009.

19.

Antitumorigenesis of antioxidants in a transgenic Rac1 model of Kaposi's sarcoma.

Ma Q, Cavallin LE, Yan B, Zhu S, Duran EM, Wang H, Hale LP, Dong C, Cesarman E, Mesri EA, Goldschmidt-Clermont PJ.

Proc Natl Acad Sci U S A. 2009 May 26;106(21):8683-8. doi: 10.1073/pnas.0812688106. Epub 2009 May 8.

20.

In vivo-restricted and reversible malignancy induced by human herpesvirus-8 KSHV: a cell and animal model of virally induced Kaposi's sarcoma.

Mutlu AD, Cavallin LE, Vincent L, Chiozzini C, Eroles P, Duran EM, Asgari Z, Hooper AT, La Perle KM, Hilsher C, Gao SJ, Dittmer DP, Rafii S, Mesri EA.

Cancer Cell. 2007 Mar;11(3):245-58. Erratum in: Cancer Cell. 2007 May;11(5):471.

21.

Kaposi sarcoma-associated herpesvirus and other viruses in human lymphomagenesis.

Cesarman E, Mesri EA.

Curr Top Microbiol Immunol. 2007;312:263-87. Review.

PMID:
17089801
22.

Pathogenesis of viral lymphomas.

Cesarman E, Mesri EA.

Cancer Treat Res. 2006;131:49-88. Review. No abstract available.

PMID:
16704166
23.

Kaposi's sarcoma associated herpesvirus G protein-coupled receptor immortalizes human endothelial cells by activation of the VEGF receptor-2/ KDR.

Bais C, Van Geelen A, Eroles P, Mutlu A, Chiozzini C, Dias S, Silverstein RL, Rafii S, Mesri EA.

Cancer Cell. 2003 Feb;3(2):131-43.

24.

Copper deficiency induced by tetrathiomolybdate suppresses tumor growth and angiogenesis.

Pan Q, Kleer CG, van Golen KL, Irani J, Bottema KM, Bias C, De Carvalho M, Mesri EA, Robins DM, Dick RD, Brewer GJ, Merajver SD.

Cancer Res. 2002 Sep 1;62(17):4854-9.

25.
26.

Activated fibroblast growth factor receptor 3 is an oncogene that contributes to tumor progression in multiple myeloma.

Chesi M, Brents LA, Ely SA, Bais C, Robbiani DF, Mesri EA, Kuehl WM, Bergsagel PL.

Blood. 2001 Feb 1;97(3):729-36.

PMID:
11157491
28.

Viral G protein-coupled receptor and Kaposi's sarcoma: a model of paracrine neoplasia?

Cesarman E, Mesri EA, Gershengorn MC.

J Exp Med. 2000 Feb 7;191(3):417-22. No abstract available.

30.

Virus-associated lymphomas.

Cesarman E, Mesri EA.

Curr Opin Oncol. 1999 Sep;11(5):322-32. Review.

PMID:
10505767
31.

Targeting AIDS-Kaposi's sarcoma.

Mesri EA.

Nat Med. 1999 Jul;5(7):738-9. No abstract available.

PMID:
10395315
33.
34.

G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator.

Bais C, Santomasso B, Coso O, Arvanitakis L, Raaka EG, Gutkind JS, Asch AS, Cesarman E, Gershengorn MC, Mesri EA.

Nature. 1998 Jan 1;391(6662):86-9. Erratum in: Nature 1998 Mar 12;392(6672):210. Gerhengorn MC [corrected to Gershengorn MC].

PMID:
9422510
36.

Human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus is a new transmissible virus that infects B cells.

Mesri EA, Cesarman E, Arvanitakis L, Rafii S, Moore MA, Posnett DN, Knowles DM, Asch AS.

J Exp Med. 1996 May 1;183(5):2385-90.

38.
39.

Cytotoxic effects of vascular smooth muscle cells of the chimeric toxin, heparin binding TGF alpha-Pseudomonas exotoxin.

Fu YM, Mesri EA, Yu ZX, Kreitman RJ, Pastan I, Epstein SE.

Cardiovasc Res. 1993 Sep;27(9):1691-7.

PMID:
8287449
41.

Major Trypanosoma cruzi antigenic determinant in Chagas' heart disease shares homology with the systemic lupus erythematosus ribosomal P protein epitope.

Mesri EA, Levitus G, Hontebeyrie-Joskowicz M, Dighiero G, Van Regenmortel MH, Levin MJ.

J Clin Microbiol. 1990 Jun;28(6):1219-24.

Supplemental Content

Loading ...
Support Center